|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 419.70 INR | -0.42% |
|
-5.44% | -7.43% |
| 25/12 | Akums Drugs and Pharmaceuticals says unit gets total tax demand order of 5.4 million rupees | RE |
| 16/12 | Akums Drugs and Pharmaceuticals gets additional penalty worth 18 million rupees | RE |
| Capitalization | 6.43TCr 70Cr 60Cr 56Cr 52Cr 97Cr 103.73Cr 638.99Cr 252.86Cr 3.04TCr 263.07Cr 257.69Cr 11TCr | P/E ratio 2026 * |
25.3x | P/E ratio 2027 * | 17.7x |
|---|---|---|---|---|---|
| Enterprise value | 6.43TCr 70Cr 60Cr 56Cr 52Cr 97Cr 103.73Cr 638.99Cr 252.86Cr 3.04TCr 263.07Cr 257.69Cr 11TCr | EV / Sales 2026 * |
1.52x | EV / Sales 2027 * | 1.34x |
| Free-Float |
17.88% | Yield 2026 * |
-
| Yield 2027 * | - |
More valuation ratios
* Estimated data
More news
Last Transcript: Akums Drugs and Pharmaceuticals Limited
| 1 day | -0.42% | ||
| 1 week | -5.44% | ||
| Current month | -7.43% | ||
| 1 month | -1.76% | ||
| 3 months | -10.10% | ||
| 6 months | -24.08% | ||
| Current year | -7.43% |
| 1 week | 409.3 |  | 445.8 |
| 1 month | 409.3 | | 480.5 |
| Current year | 409.3 | | 458 |
| 1 year | 405 | | 627.9 |
| 3 years | 405 | | 1,175.9 |
| 5 years | 405 | | 1,175.9 |
| 10 years | 405 | | 1,175.9 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sandeep Jain
CEO | Chief Executive Officer | 58 | 19/12/2004 |
Sanjeev Jain
CEO | Chief Executive Officer | 59 | 19/12/2004 |
| Director | Title | Age | Since |
|---|---|---|---|
Sanjeev Jain
BRD | Director/Board Member | 59 | 19/12/2004 |
Sandeep Jain
BRD | Director/Board Member | 58 | 19/12/2004 |
| Director/Board Member | 47 | 17/01/2024 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.42% | -5.44% | -33.01% | - | 70Cr | |
| +3.58% | +0.49% | +45.28% | +211.65% | 97TCr | |
| -0.09% | -0.25% | +47.15% | +29.20% | 53TCr | |
| +0.99% | -2.59% | +25.22% | +44.49% | 38TCr | |
| +0.58% | +0.96% | +28.57% | +17.58% | 37TCr | |
| +1.12% | -6.15% | +21.82% | +21.98% | 28TCr | |
| +0.14% | -1.29% | +28.20% | +34.10% | 28TCr | |
| +1.52% | +0.09% | +15.45% | +1.06% | 28TCr | |
| +3.43% | +2.13% | -32.65% | -19.98% | 26TCr | |
| +3.81% | +4.45% | +25.03% | +30.53% | 19TCr | |
| Average | +0.45% | -1.29% | +17.11% | +41.18% | 35.2TCr | |
| Weighted average by Cap. | +0.26% | -0.68% | +29.25% | +73.74% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 4.24TCr 46Cr 40Cr 37Cr 34Cr 64Cr 68Cr 421.5Cr 166.8Cr 2TCr 173.53Cr 169.98Cr 7.32TCr | 4.81TCr 52Cr 45Cr 42Cr 39Cr 72Cr 78Cr 477.97Cr 189.14Cr 2.27TCr 196.78Cr 192.75Cr 8.3TCr |
| Net income | 257.65Cr 2.81Cr 2.4Cr 2.23Cr 2.09Cr 3.88Cr 4.16Cr 26Cr 10Cr 121.77Cr 11Cr 10Cr 444.8Cr | 366.95Cr 4.01Cr 3.43Cr 3.18Cr 2.98Cr 5.53Cr 5.92Cr 36Cr 14Cr 173.43Cr 15Cr 15Cr 633.49Cr |
| Net Debt | - | - |
More financial data
* Estimated data
Employees
7,536
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 21/26/21 | 419.70 ₹ | -0.42% | 1,41,510 |
| 20/26/20 | 421.45 ₹ | -3.64% | 1,03,460 |
| 19/26/19 | 437.35 ₹ | -1.52% | 96,072 |
| 16/26/16 | 444.10 ₹ | -0.08% | 60,395 |
| 14/26/14 | 444.45 ₹ | +0.14% | 93,037 |
End-of-day quote NSE India S.E., January 21, 2026
More quotes
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
419.70INR
Average target price
646.67INR
Spread / Average Target
+54.08%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- AKUMS Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition